Warfarin-Aspirin Recurrent Stroke Study (WARSS) Trial: Is Warfarin Really a Reasonable Therapeutic Alternative to Aspirin for Preventing Recurrent Noncardioembolic Ischemic Stroke?

Stroke - United States
doi 10.1161/01.str.0000016922.22707.27
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Cliostazol Demonstrates Noninferiority to Aspirin for the Prevention of Recurrent Stroke

Nature Reviews Neurology
Molecular NeuroscienceNeurologyCellular
2011English

Warfarin Versus Warfarin and Aspirin in Atrial Fibrillation

Neurological Bulletin
2011English

Warfarin-Flucloxacillin Interaction Presenting as Cardioembolic Ischemic Stroke

European Journal of Clinical Pharmacology
MedicinePharmacology
2010English

Cost-Effectiveness of Apixaban Compared With Aspirin for Stroke Prevention in Atrial Fibrillation Among Patients Unsuitable for Warfarin

Circulation. Cardiovascular quality and outcomes
MedicineCardiovascular MedicineCardiology
2012English

Impact of Aspirin on Warfarin Control as Measured by Time in Therapeutic Range

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2018English

Recurrent Risk of Ischemic Stroke Due to Vertebrobasilar Dolichoectasia

BMC Neurology
MedicineNeurology
2019English

Risk of Recurrent Arterial Ischemic Stroke in Childhood

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2016English

Combination Therapy With Beraprost Sodium and Aspirin for Acute Ischemic Stroke: A Single-Center Retrospective Study

Journal of International Medical Research
BiochemistryMedicineCell Biology
2019English

Warfarin in Patients With Cardioembolic Stroke

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy